{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:27:10Z","timestamp":1793500030829,"version":"4.5.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Natural Killer cells (NKs) represent the innate counterpart of TCR\u03b1\u03b2 lymphocytes and are characterized by a high anti-tumor and an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as an additional inhibitory receptor. Specifically, PD-1 was identified on a subpopulation of terminally differentiated NKs from healthy adults with previous HCMV infection. So far it is unknown whether PD-1 appears during NK-cell development and whether this process is directly or indirectly related to HCMV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyzed the expression and function of PD-1 on Cord Blood derived NKs (CB-NKs) on a large cohort of newborns through multiparametric cytofluorimetric analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified PD-1 on CB-NKs in more than of half the newborns analyzed. PD-1 was present on CD56\n                      <jats:sup>dim<\/jats:sup>\n                      NKs, and particularly abundant on CD56\n                      <jats:sup>neg<\/jats:sup>\n                      NKs, but only rarely present on CD56\n                      <jats:sup>bright<\/jats:sup>\n                      NKs. Importantly, unlike in adult healthy donors, in CB-NKs PD-1 is co-expressed not only with KIR, but also with NKG2A. PD-1 expression was independent of HCMV mother seropositivity and occurs in the absence of HCMV infection\/reactivation during pregnancy. Notably, PD-1 expressed on CB-NKs was functional and mediated negative signals when triggered.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To our understanding, this study is the first to report PD-1 expression on CB derived NKs and its features in perinatal conditions. These data may prove important in selecting the most suitable CB derived NK cell population for the development of different immunotherapeutic treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1183215","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T05:41:41Z","timestamp":1687585301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1"],"prefix":"10.3389","volume":"14","author":[{"given":"Marco","family":"Greppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Obino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Rebaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Della Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sivori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ubezio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marcenaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.smim.2019.03.004","article-title":"NK cells to cure cancer","volume":"41","author":"di Vito","year":"2019","journal-title":"Semin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.3390\/cancers12123504","article-title":"Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes","volume":"12","author":"Pesce","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01963\/full","article-title":"PD\/1-PD-Ls checkpoint: insight on the potential role of NK cells","volume":"10","author":"Pesce","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01363","article-title":"Editorial: NK cell subsets in health and disease: new developments","volume":"8","author":"Marcenaro","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verg\u00e8s","year":"2010","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3324\/haematol.2015.134155","article-title":"Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing \u03b1\u03b2+T and b cell-depleted hematopoietic stem cell transplantation for hematological malignancies","volume":"101","author":"Muccio","year":"2016","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.smim.2022.101706","article-title":"Adaptive NK cell response to human cytomegalovirus: facts and open issues","volume":"65","author":"L\u00f3pez-Botet","year":"2023","journal-title":"Semin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1750-0","article-title":"Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance","volume":"65","author":"Manser","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13055-y","article-title":"Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets","volume":"10","author":"Belkina","year":"2019","journal-title":"Nat Commun"},{"key":"B15","unstructured":"Morpheus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.7.3992","article-title":"IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors","volume":"174","author":"Marcenaro","year":"2005","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1853314","DOI":"10.1080\/2162402X.2020.1853314","article-title":"Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients","volume":"10","author":"Reina-Ortiz","year":"2020","journal-title":"Oncoimmunology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584099","article-title":"Cord-blood natural killer cell-based immunotherapy for cancer","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","article-title":"Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus","volume":"119","author":"della Chiesa","year":"2012","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1557030","DOI":"10.1080\/2162402X.2018.1557030","article-title":"PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression","volume":"8","author":"Mariotti","year":"2018","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature20105","article-title":"Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway","volume":"539","author":"Yu","year":"2016","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0141-9","article-title":"PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua","volume":"12","author":"Vacca","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center b cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.12.001","article-title":"Natural killer cell education and the response to infection and cancer therapy: stay tuned","volume":"39","author":"Boudreau","year":"2018","journal-title":"Trends Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00711-19","article-title":"PD-1 expression on NK cells in malaria-exposed individuals is associated with diminished natural cytotoxicity and enhanced antibody-dependent cellular cytotoxicity","volume":"88","author":"Moebius","year":"2020","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","article-title":"Antigen-presenting cell-intrinsic PD-1 neutralizes PD-L1 in cis to attenuate PD-1 signaling in T cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The mechanism of anti-PD-L1 antibody efficacy against PD-L1-Negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0813443","article-title":"Negative role of inducible PD-1 on survival of activated dendritic cells","volume":"95","author":"Park","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","volume":"27","author":"Ogishi","year":"2021","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn073","article-title":"Human NK cells directly recognize mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC","volume":"20","author":"Marcenaro","year":"2008","journal-title":"Int Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.29.437486v1","article-title":"PD-1 expression on NK cells can be related to cytokine stimulation and tissue residency","author":"Wagner","year":"2021","journal-title":"bioRxiv"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1316713","article-title":"Advances in umbilical cord blood cell therapy: the present and the future","volume":"17","author":"Berglund","year":"2017","journal-title":"Expert Opin Biol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1183215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T13:14:30Z","timestamp":1687871670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1183215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2023.1183215"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1183215","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"article-number":"1183215"}}